491 related articles for article (PubMed ID: 34180396)
1. A novel decoy strategy for polymyxin resistance in
Park J; Kim M; Shin B; Kang M; Yang J; Lee TK; Park W
Elife; 2021 Jun; 10():. PubMed ID: 34180396
[TBL] [Abstract][Full Text] [Related]
2. Genomic and phenotypic analyses of multidrug-resistant
Kim M; Park J; Park W
Virulence; 2021 Dec; 12(1):150-164. PubMed ID: 33372826
[TBL] [Abstract][Full Text] [Related]
3. Synergistic activity of polymyxin B combined with vancomycin against carbapenem-resistant and polymyxin-resistant Acinetobacter baumannii: first in vitro study.
Shinohara DR; Menegucci TC; Fedrigo NH; Migliorini LB; Carrara-Marroni FE; Maria Dos Anjos M; Cardoso CL; Nishiyama SAB; Tognim MCB
J Med Microbiol; 2019 Mar; 68(3):309-315. PubMed ID: 30663954
[TBL] [Abstract][Full Text] [Related]
4. Sub-minimum inhibitory concentrations of colistin and polymyxin B promote Acinetobacter baumannii biofilm formation.
Sato Y; Unno Y; Ubagai T; Ono Y
PLoS One; 2018; 13(3):e0194556. PubMed ID: 29554105
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with polymyxin B and netropsin against clinical isolates of multidrug-resistant Acinetobacter baumannii.
Chung JH; Bhat A; Kim CJ; Yong D; Ryu CM
Sci Rep; 2016 Jun; 6():28168. PubMed ID: 27306928
[TBL] [Abstract][Full Text] [Related]
6. Comparative Proteomics of Outer Membrane Vesicles from Polymyxin-Susceptible and Extremely Drug-Resistant Klebsiella pneumoniae.
Hussein M; Jasim R; Gocol H; Baker M; Thombare VJ; Ziogas J; Purohit A; Rao GG; Li J; Velkov T
mSphere; 2023 Feb; 8(1):e0053722. PubMed ID: 36622250
[TBL] [Abstract][Full Text] [Related]
7. Semi-mechanistic PK/PD modelling of combined polymyxin B and minocycline against a polymyxin-resistant strain of Acinetobacter baumannii.
Aranzana-Climent V; Buyck JM; Smani Y; Pachón-Diaz J; Marchand S; Couet W; Grégoire N
Clin Microbiol Infect; 2020 Sep; 26(9):1254.e9-1254.e15. PubMed ID: 32006693
[TBL] [Abstract][Full Text] [Related]
8. Constitutive Phenotypic Modification of Lipid A in Clinical Acinetobacter baumannii Isolates.
Kim SH; Yun S; Park W
Microbiol Spectr; 2022 Aug; 10(4):e0129522. PubMed ID: 35861511
[TBL] [Abstract][Full Text] [Related]
9. Strategies for the treatment of polymyxin B-resistant Acinetobacter baumannii infections.
Menegucci TC; Albiero J; Migliorini LB; Alves JL; Viana GF; Mazucheli J; Carrara-Marroni FE; Cardoso CL; Tognim MC
Int J Antimicrob Agents; 2016 May; 47(5):380-5. PubMed ID: 27068675
[TBL] [Abstract][Full Text] [Related]
10. Using machine learning to optimize antibiotic combinations: dosing strategies for meropenem and polymyxin B against carbapenem-resistant Acinetobacter baumannii.
Smith NM; Lenhard JR; Boissonneault KR; Landersdorfer CB; Bulitta JB; Holden PN; Forrest A; Nation RL; Li J; Tsuji BT
Clin Microbiol Infect; 2020 Sep; 26(9):1207-1213. PubMed ID: 32061797
[TBL] [Abstract][Full Text] [Related]
11. 6-Bromo-2-naphthol from Silene armeria extract sensitizes Acinetobacter baumannii strains to polymyxin.
Kang M; Kim W; Lee J; Jung HS; Jeon CO; Park W
Sci Rep; 2022 May; 12(1):8546. PubMed ID: 35595766
[TBL] [Abstract][Full Text] [Related]
12. Synergistic antibacterial effect of ultrasound microbubbles combined with chitosan-modified polymyxin B-loaded liposomes on biofilm-producing
Fu YY; Zhang L; Yang Y; Liu CW; He YN; Li P; Yu X
Int J Nanomedicine; 2019; 14():1805-1815. PubMed ID: 30880981
[TBL] [Abstract][Full Text] [Related]
13. Lipid A in outer membrane vesicles shields bacteria from polymyxins.
Burt M; Angelidou G; Mais CN; Preußer C; Glatter T; Heimerl T; Groß R; Serrania J; Boosarpu G; Pogge von Strandmann E; Müller JA; Bange G; Becker A; Lehmann M; Jonigk D; Neubert L; Freitag H; Paczia N; Schmeck B; Jung AL
J Extracell Vesicles; 2024 May; 13(5):e12447. PubMed ID: 38766978
[TBL] [Abstract][Full Text] [Related]
14. The polymyxin derivative NAB739 is synergistic with several antibiotics against polymyxin-resistant strains of Escherichia coli, Klebsiella pneumoniae and Acinetobacter baumannii.
Tyrrell JM; Aboklaish AF; Walsh TR; Vaara T; Vaara M
Peptides; 2019 Feb; 112():149-153. PubMed ID: 30586602
[TBL] [Abstract][Full Text] [Related]
15. Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii.
Tran TB; Cheah SE; Yu HH; Bergen PJ; Nation RL; Creek DJ; Purcell A; Forrest A; Doi Y; Song J; Velkov T; Li J
J Antibiot (Tokyo); 2016 Jun; 69(6):415-21. PubMed ID: 26669752
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii.
Thomas VM; Brown RM; Ashcraft DS; Pankey GA
Int J Antimicrob Agents; 2019 May; 53(5):663-668. PubMed ID: 30880230
[TBL] [Abstract][Full Text] [Related]
17. Insights into collateral susceptibility and collateral resistance in Acinetobacter baumannii during antimicrobial adaptation.
Dawan J; Kim JC; Ahn J
Lett Appl Microbiol; 2021 Aug; 73(2):168-175. PubMed ID: 33893654
[TBL] [Abstract][Full Text] [Related]
18. Diversity of polymyxin resistance mechanisms among Acinetobacter baumannii clinical isolates.
Girardello R; Visconde M; Cayô R; Figueiredo RC; Mori MA; Lincopan N; Gales AC
Diagn Microbiol Infect Dis; 2017 Jan; 87(1):37-44. PubMed ID: 27776788
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of polymyxin B against carbapenem-resistant Acinetobacter baumannii.
Thamlikitkul V; Tiengrim S; Seenama C
J Med Assoc Thai; 2014 Dec; 97(12):1254-8. PubMed ID: 25764631
[TBL] [Abstract][Full Text] [Related]
20. Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii.
Rao GG; Ly NS; Diep J; Forrest A; Bulitta JB; Holden PN; Nation RL; Li J; Tsuji BT
Int J Antimicrob Agents; 2016 Sep; 48(3):331-6. PubMed ID: 27449542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
